Literature DB >> 32336444

Why we should create uniform pharmacy education requirements across different countries: A review of current requirements and the need for global regulator input.

Ricarda Micallef1, Reem Kayyali2.   

Abstract

INTRODUCTION: Currently, there is no globally agreed upon standard for pharmacist undergraduate education, continuing professional development (CPD) or continuing education (CE), although global frameworks are available. Supporting uniformity globally from an undergraduate degree to ongoing lifelong learning will be reviewed. The continuing need for regulator input will also be discussed. COMMENTARY: Across the globe, multiple degree pathways exist to enter the pharmacist profession. These include a bachelor of science, a masters, and an increasing number of doctor of pharmacy degrees. Various models exist for lifelong learning (CPD and CE) requirements. While frameworks exist for a global model, there is limited evidence of progress. IMPLICATIONS: This is call for pharmacy regulators globally to work together to identify global standards, with clear measurable outcomes, to share best practice and provide consistent patient care globally.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Continuing education; Continuing professional development; Global; Lifelong learning; Pharmacy

Mesh:

Year:  2020        PMID: 32336444     DOI: 10.1016/j.cptl.2020.01.004

Source DB:  PubMed          Journal:  Curr Pharm Teach Learn        ISSN: 1877-1297


  2 in total

1.  Interviews with Global Pharmacists and Healthcare Professionals in Great Britain to Establish Personal Experiences around Professional Development Activity.

Authors:  Ricarda Micallef; Reem Kayyali
Journal:  Pharmacy (Basel)       Date:  2022-01-01

2.  Exploring the impact of the United States-based accreditation council for pharmacy education certification on pharmacy education outside the United States.

Authors:  Omar Attarabeen; Fadi Alkhateeb; Reza Karimi
Journal:  Saudi Pharm J       Date:  2021-12-31       Impact factor: 4.562

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.